Christiaan de Koning
Saïd Business School
University of Oxford
Park End Street
Christiaan’s research focuses on entrepreneurial venture formation, technology & innovation, entrepreneurship, institutions, and ecosystems.
He holds a DPhil (PhD) from Saïd Business School, where he wrote his thesis under Professor Sue Dopson, Professor Michael Smets, and Dr Javier Lezaun. Throughout his doctoral studies he was funded by the Saïd Business School-Saïd Business School Foundation Scholarship.
Prior to starting his doctorate, Christiaan was a Visiting Fellow at InSIS in the BioProperty Research Group. He received an MPhil degree in Science and Technology Studies from Maastricht University and an Honours degree in Liberal Arts and Sciences from University College Maastricht. He has affiliations with the Oxford Institute for Science, Innovation and Society, and Christ Church College.
He has been an advisor to a variety of parties, including governing bodies such as the House of Lords’ Science and Technology Select Committee, the European Commission, news outlets, and numerous life science start-ups and accelerators.
Christiaan is involved with a number of entrepreneurship and innovation initiatives within Oxford. For instance, he founded Founders & Funders, an international community and digital event series that brings notable alumni, experts, and funders in conversation with researchers and executive students at the coalface of science and business.
Christiaan’s main areas of expertise are:
- Technology & innovation
- Organisation theory
- Institutional theory
- Institutional logics
- Institutional complexity
- Practice theory
- Strategic management
- Entrepreneurial firm formation
- Life science ventures
- Qualitative research methods and comparative case study research
His current research assesses the social, organisational, and economic implications of emergent technologies, with a focus on the formation and development of entrepreneurial ventures. Some of his recent work explores the translation of innovations from out of the laboratory into scalable products, services, and organisations: in particular, the commercialisation of emerging biotechnologies such as the genome editing platform CRISPR.
Christiaan De Koning. (2020). The co-constitution of technologies, organisations, and institutions in the process of commercialisation: the case of CRISPR (Doctoral dissertation, University of Oxford).
Christiaan De Koning, André Sica De Campos, Sarah Hartley, Javier Lezaun and Lea Velho (2017) Responsible Innovation and political accountability: genetically modified mosquitoes in Brazil Journal of Responsible Innovation, 4 (1) pp. 5-23.